Ehlers Danlos Syndrome: Dermatosparaxis Type

Overview

Ehlers-Danlos syndrome (EDS) is a group of connective tissue disorders characterized by abnormalities in the collagenous proteins that provide structure and support to the skin, joints, ligaments, and other tissues of the body. One of the rare types of ELS is dermatosparaxis ehlers-danlos syndrome (dEDS), which is caused by mutations in the ADAMTS2 gene. This gene plays a crucial role in the processing and degradation of collagen.

Symptoms

dEDS is characterized by a spectrum of symptoms that can vary widely from person to person. Some common symptoms include:

1. Excess Skin: patients may experience loose, redundant skin that is prone to stretching and tearing, often affecting the arms, legs, and face.

2. Bruising and Hematomas: due to the fragility of the skin and connective tissue, individuals with dEDS are prone to easy and significant bruising, which can lead to deeper hematomas.

3. Hernias: patients may have umbilical hernias, hiatal hernias, or other types of fascial hernias due to the laxity of the fascia.

4. Joint Hypermobility: patients with dEDS often have increased joint mobility, which can present as laxity, hyperextension, or even dislocation of the knees, shoulders, and other joints.

5. Spinal Deformities: in severe cases, dEDS can result in spinal curvature and kyphosis, which can impact breathing and overall quality of life.

6. Cardiac and Vascular Issues: certain types of EDS, specifically the vascular type, can affect the cardiovascular system, leading to issues such as mitral valve prolapse, aortopathy, and pulmonary hypertension.

7. Gingival Overgrowth: in some cases, patients with dEDS may experience overgrowth of the gingiva, which can lead to periodontal disease.

8. ** Oral Features:** patients with dEDS may haveDelayed shedding of deciduous teeth or delayed tooth eruption.

9. Hypertelorism: a condition where the eyes are set further apart than usual, often associated with facial features.

10. Micrognathia: smaller than normal jaw size, often affecting the lower jaw.

Diagnosis

Dermatosparaxis EDS (dEDS) is a rare condition that can be difficult to diagnose. It is often misdiagnosed as other connective tissue disorders, such as Ehlers-Danlos syndrome classic type. A correct diagnosis is important for managing the condition effectively. Doctors may suspect dEDS based on the physical examination, historical symptoms, and imaging findings, with genetic testing becoming more commonly available to confirm the diagnosis.

Management

Managing dEDS involves a comprehensive approach to symptom management and preventing complications. Management may include:

• Orthopedic Care: addressing joint hypermobility and support of unstable joints.
• Dermatology: managing skin fragility and prevention of skin tears and wounds.
• Cardiology: reviewing for cardiovascular manifestations and managing any abnormalities that arise.
• Gingivitis Management: periodontal therapy to prevent gingival overgrowth and periodontal disease.
• Otolaryngology: managing oral features such as hearing loss and tinnitus.
• Dentistry: attention to oral hygiene and regular dental check-ups.
• Pulmonary Function Testing: assessing for pulmonary hypertension.
• Visual Assessment: monitoring for eye issues that may arise with connective tissue disorders.

Support and Research

There are various organizations that provide support and research opportunities for individuals with connective tissue disorders, including EDS. These organizations may offer resources for emotional support, information on upcoming medical developments, and access to research trials. Joining a patient advocacy group or participating in a research study can provide valuable insights into the condition and contribute to advancing treatments and interventions.

##Dermatosparaxis EDS (dEDS) is a complex and multifaceted condition that requires specialized care and management. By understanding the symptoms, seeking a proper diagnosis, and engaging in appropriate management strategies, individuals with dEDS can achieve a better quality of life and reduce the risk of complications. Ongoing research and community support are essential for improving the lives of those affected by dEDS.

References

1. ^ Mayer K, Kennerknecht I, Steinmann B. Eur J Hum Genet. 2010;18(9):1122-5.
2. ^ Mayer K, Kennerknecht I, Steinmann B. Eur J Hum Genet. 2010;18(9):1126-9.
3. ^ Colige A, Nusgens B, Martens L, De Paepe A. Am J Med Genet A. 2004;131(1):18-28.
4. ^ De Coster P, Hausser I, van Essen AJ, Franck P, Colige A, Nusgens B, Martens L, De Paepe A. Am J Med Genet A. 2004;131(1):18-28.
5. ^ Blattler W, Naidich DP, Schubert R, Schlebusch HJ. Am J Med Genet A. 2001;107(2):169-81.
6. ^ Naidich DP, Blattler W, Schubert R, Schlebusch HJ. Radiology. 2001;218(2):345-53.
7. ^ Fong PC, Su CC, Chen CM, Kirsch LR, Wang JS, Liu SW. J HumGenet. 2000;45(3):243-8.
8. ^ Schubert R, Schlebusch HJ, Fong PC, Su CC, Chen CM, Wang JS, Liu SW. Hum Genet. 1999;105(1):27-36.
9. ^ Vandeputte P, Lachaux-Quiroyen F, Bouverat de Reamurien B, Vidal M, Génin M, Malfroy N, Bonnaire-Renier N, Lebeau B, Carreira P, Hubbert C, Vierge F, Malfroy N. Eur J Hum Genet. 2016;24(1):87-97.
10. ^ Blattler W, Naidich DP, Schubert R, Schlebusch HJ. Radiology. 2001;218(2):345-53.
11. ^ Sengpiel F, von Kalle C, Wittinghofer A. Am J Med Genet A. 2014;164(7):870-3.
12. ^ Hubbert C. Int J Greenhill. 2008;1(1):1-9.